NIDDK Centers for Diabetes Translation Research (P30) | Apply Online

FAQs: NIDDK Centers for Diabetes Translation Research (CDTR) (P30) - RFA-DK-10-009

What is the funding opportunity?

This opportunity is the NIDDK Centers for Diabetes Translation Research (CDTR) (P30), Funding Opportunity Number RFA-DK-10-009. It is an NIH funding announcement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) focused on building institutional center infrastructure to strengthen Type 2 diabetes translation research.

What is the main purpose of a CDTR?

The central purpose is to help institutions create formal centers that make it easier for investigators to move evidence and research findings from clinical settings into real-world practice and community environments. The emphasis is on improving the pipeline from "bedside to practice and the community" for Type 2 diabetes prevention and care.

What kind of research does this center program support?

The program supports translation research that tests, adapts, and implements evidence-based diabetes interventions in healthcare systems, primary care, and community settings. It is aimed at applied work that addresses practical dissemination and implementation challenges in real-world environments.

Does this fund a single research project or shared infrastructure?

This uses the NIH P30 Center Core Grant mechanism, which is designed to support shared infrastructure (center resources and services) rather than a single standalone research project.

What does "center infrastructure" mean in this announcement?

In this context, infrastructure refers to an institutional hub that provides shared resources, expertise, and services that investigators can use to conduct translation research more efficiently. The center is expected to organize these shared services into "cores."

What are "cores" in a CDTR?

"Cores" are centralized resources and services offered by the center to support multiple investigators. Based on the description provided, cores may help investigators with study design, data management, community-engaged work, outcomes measurement, and addressing dissemination and implementation issues that arise when moving interventions into practice and community settings.

What does the FOA mean by multidisciplinary collaboration?

The FOA emphasizes that all center activities should enhance multidisciplinary work. The expectation is that a CDTR brings together multiple fields and stakeholder perspectives, including clinical, behavioral, public health, and implementation-focused teams, to address complex translation problems in Type 2 diabetes prevention and care.

What is the funding agency and institute for this opportunity?

The funding agency is the National Institutes of Health (NIH), and the issuing institute is the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

What is the total funding level and project period mentioned?

NIDDK indicated a total funding level of up to $3,000,000 per year for five years under this announcement.

How many awards were anticipated?

The announcement anticipated a maximum of seven awards.

What is the award ceiling listed in the provided information?

The award ceiling is listed as $200,000 in the source data provided.

Is cost sharing or matching required?

No. The information provided states there is no cost sharing or matching requirement.

What topic area does this opportunity fall under?

The opportunity is categorized under the Health area, with a focus that includes food and nutrition, and it is centered on Type 2 diabetes translation research.

What CFDA number is associated with this program?

The program is listed under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).

Who is eligible to apply?

Eligibility is broad. It includes public and private institutions of higher education, state governments, nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) nonprofits), and for-profit organizations that are not small businesses.

Are minority-serving institutions explicitly included as eligible applicants?

Yes. The eligibility text explicitly recognizes additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, and other entities as clarified in the full eligibility text.

When was the FOA posted and created?

Administrative details in the source data show the FOA was posted and created on August 24, 2010.

What is the closing date listed for this opportunity?

The closing date is listed as November 17, 2010. The source data also shows an "original closing date" field of November 17, 2011.

When was this opportunity archived?

The archive date is listed as December 18, 2010.

Where was the full announcement made available?

The full announcement was made available via the NIH Grants Guide (as noted in the source data).

Who should be contacted for access or technical issues?

For access or technical issues, contact help is routed through the NIH Office of Extramural Research (OER) webmaster, based on the information provided.

What is the practical goal of the CDTR model for investigators?

The practical goal is for the center to function as an enabling hub that increases the efficiency, productivity, and overall effectiveness of Type 2 diabetes translation research by offering shared cores and expertise that investigators can use to accelerate applied research in healthcare and community settings.